SERVICES
Life Sciences Strategy & Solutions
Integrated scientific, clinical, regulatory, and lifecycle support designed around where your innovation is today and where it needs to go next.
Embedded Files
HOW WE HELP
HOW WE HELP
OUR SIX STAGE APPROACH
OUR SIX STAGE APPROACH
Healthcare development is rarely linear. Organizations may need support at the beginning of translation, during clinical development, approaching authorization, or years after commercialization.
ClinicalMe's services are organized around six stages:
DISCOVER > DEFINE > BUILD > PROVE > AUTHORIZE > SUSTAIN
Clients can engage us at any stage or across multiple stages as their needs evolve.
DISCOVER
PROVE
DEFINE
AUTHORIZE
BUILD
SUSTAIN
Who We Serve
Who We Serve
Supporting healthcare innovators from emerging concepts to established products.
ClinicalMe works with organizations across the healthcare innovation ecosystem, providing focused expertise or integrated support as development needs evolve.
Startups & Emerging Companies — Building evidence, development, regulatory, and quality strategies as innovations move toward clinical and commercial readiness.
Established Medical Device, Diagnostic & Biotechnology Companies — Expanding internal capabilities, addressing complex evidence and regulatory needs, and supporting products throughout the lifecycle.
Healthcare Innovators & Clinical Entrepreneurs — Evaluating unmet needs, emerging technologies, and early concepts before significant development investment.
Universities, Research Institutions & Technology Transfer Teams — Assessing translational opportunities and helping promising research move toward viable development pathways.
Investors, Accelerators & Innovation Organizations — Providing evidence-driven scientific, clinical, regulatory, and translational insight to support evaluation and development decisions.
Strategic Partners & Development Organizations — Providing specialized clinical, evidence, regulatory, and lifecycle expertise within larger multidisciplinary programs.
Whether you need a single specialized deliverable or coordinated support across multiple lifecycle stages, ClinicalMe meets your organization where the innovation is today.
DISCOVER
DISCOVER
Identify Opportunities Worth Investigating
Before development begins, organizations need to understand the clinical problem, existing evidence, scientific landscape, and unanswered questions.
ClinicalMe supports early investigation of emerging opportunities through structured evidence analysis and translational research.
Services may include:
Unmet Need Assessment
Evidence Landscape & Gap Analysis
Scientific & Clinical Landscape Research
Literature Intelligence
Technology Landscape Assessment
Translational Opportunity Assessment
Early Clinical Landscape Assessment
DEFINE
DEFINE
Translate Opportunity Into Development Strategy
Promising innovation requires more than a good idea. ClinicalMe helps organizations define what successful development would require and identify the evidence, capabilities, risks, and decisions ahead.
Services may include:
Clinical Strategy
Regulatory Strategy
Evidence Strategy
Clinical Development Planning
Feasibility Assessment
Development Roadmaps
Development Risk & Evidence Gap Assessment
Intended Purpose/Clinical Use Strategy
Early Lifecycle Planning
BUILD
BUILD
Establish the Foundation for Regulated Development
ClinicalMe helps organization establish the systems, processes, capabilities, and partnerships required to support compliant healthcare product development.
Services may include:
Quality System Development
Document Control
Clinical Research Infrastructure
Clinical Quality Processes
Risk Management Integration
Clinical Development Systems
Vendor & Partner Strategy
Development Documentation
SOP and Work Instruction Development
Training Frameworks
Where specialized technical expertise is required, ClinicalMe can coordinate qualified collaborators and strategic partners as part of an integrated development strategy.
PROVE
PROVE
Generate and Evaluate the Evidence
Clinical evidence must do more than exist. It must relevant, methodologically appropriate, appropriately weighted, and capable of supporting the conclusions being made.
Services may include:
Clinical Evidence
Clinical Evaluation Plans
Clinical Evaluation Reports
Post-Market Clinical Follow-up (PMCF) Plan
Post-Market Clinical Follow-up Evaluation Report (PMCF-ER)
Literature Search Plans
Literature Search Reports
Appraisal Plans
Appraisal Reports
State-of-the-Art Reviews
Evidence Appraisal
Evidence Gap Assessment
Claims-to-Evidence Mapping
Risk-Benefit Analysis Assessment
Performance Evidence
Performance Evaluation Plans
Performance Evaluation Reports
Scientific Validity
Analytical Assessment
Post-Market Performance Follow-up (PMPF) Plans
Post-Market Performance Follow-up (PMPF) Reports
Clinical Development
Clinical Investigation Planning
Clinical Investigation Plans/Protocols
Feasibility & Site Strategy
Study Startup Support
Clinical Project Management
Vendor/CRO Oversight
Clinical Monitoring Support
Study Closeout
Clinical Study Reports
Scientific & Medical Writing
Clinical Study Reports
Investigator's Brochures
Clinical Protocols
Scientific Publications
Regulatory Scientific Writing
Evidence Summaries
Briefing Materials
Real-World Evidence
Registry Strategy
Observational Evidence Planning
Post-Market Data Strategy
Evidence Synthesis
ClinicalMe evaluates evidence according to what it can reasonably support—not simply whether evidence exists.
AUTHORIZE
AUTHORIZE
Turn Evidence Into Defensible Regulatory Strategy
ClinicalMe helps organizations translate development evidence into regulatory documentation and strategies designed to withstand scientific and regulatory scrutiny.
Services may include:
Regulatory Strategy
Clinical Regulatory Strategy
EU MDR Clinical Documentation
Summary of Safety and Clinical Performance (SSCP)
EU IVDR Performance Evaluation Support
Regulatory Submission Writing
Submission Readiness Assessment
Clinical Evidence Gap Analysis
Notified Body Response Support
Technical Documentation Clinical Inputs
Benefit-Risk Evidence Support
Claims & Indication Support
SUSTAIN
SUSTAIN
Maintain Evidence Throughout the Product Lifecycle
Authorization is not the end of evidence generation. ClinicalMe supports ongoing evaluation of safety, performance, clinical benefit, emerging evidence, and regulatory obligations throughout the commercial lifecycle.
Services may include:
Post-Market Surveillance (PMS) Strategy
Post-Market Surveillance (PMS) Plans
Post-Market Clinical Follow-up (PMCF) Plan
Post-Market Clinical Follow-up Evaluation Report (PMCF-ER)
Post-Market Performance Follow-up (PMPF) Support
Periodic Safety Update Reports
Summary of Safety and Clinical Performance
Literature Surveillance
Lifecycle Clinical Evaluation
Real-World Evidence Strategy
Evidence Gap Monitoring
Clinical Claims Maintenance
Post-Market Evidence Strategy
Integrated Engagements
Integrated Engagements
Support that evolves with your innovation
Support that evolves with your innovation
Organizations can engage ClinicalMe for an individual deliverable, a defined development program, or coordinated support across multiple lifecycle stages.
As requirements evolve, we connect the work across stages so that evidence and insights inform each next step, maintaining continuity across development.
Page updated
Google Sites
Report abuse